Disease modifying therapies in multiple sclerosis

被引：2
|
作者：
Khatri, BO
McQuillen, MP
机构：
来源：
NEUROLOGY | 2002年 / 59卷 / 03期
关键词：
D O I：
10.1212/WNL.59.3.471
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：471 / 472
页数：2
相关论文
共 50 条
  • [31] Approved and Emerging Disease Modifying Therapies on Neurodegeneration in Multiple Sclerosis
    Bross, Madeline
    Hackett, Melody
    Bernitsas, Evanthia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (12) : 1 - 15
  • [32] Disease-modifying therapies in Chinese children with multiple sclerosis
    Yang, Fen
    Huang, De-hui
    Yang, Yang
    Wu, Wei-ping
    TURKISH JOURNAL OF PEDIATRICS, 2014, 56 (05) : 482 - 486
  • [33] Economics of Multiple Sclerosis Disease-Modifying Therapies in the USA
    Hartung, Daniel M.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2021, 21 (07)
  • [34] Alopecia in Multiple Sclerosis Patients Treated with Disease Modifying Therapies
    Porwal, Mokshal H.
    Salter, Amber
    Patel, Dhruvkumar
    Obeidat, Ahmed Z.
    JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE, 2022, 14
  • [35] Regulation of human glia by multiple sclerosis disease modifying therapies
    Healy, Luke M.
    Michell-Robinson, Mackenzie A.
    Antel, Jack P.
    SEMINARS IN IMMUNOPATHOLOGY, 2015, 37 (06) : 639 - 649
  • [36] Comparison of dropout rates of disease modifying therapies in multiple sclerosis
    Kurtuncu, M.
    Celik, S. Yildiz
    Coban, A.
    Shugaiv, E.
    Pehlivan, M.
    Akman-Demir, G.
    Eraksoy, M.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 198 - 198
  • [37] Comparing the efficacy of disease-modifying therapies in multiple sclerosis
    Mitsikostas, Dimos D.
    Goodin, Douglas S.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2017, 18 : 109 - 116
  • [38] The Use of Oral Disease-Modifying Therapies in Multiple Sclerosis
    Kretzschmar, Benedikt
    Pellkofer, Hannah
    Weber, Martin S.
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2016, 16 (04)
  • [39] Assessing the risk of multiple sclerosis disease-modifying therapies
    Ayrignac, Xavier
    Bilodeau, Philippe-Antoine
    Prat, Alexandre
    Girard, Marc
    Labauge, Pierre
    Le Lorier, Jacques
    Larochelle, Catherine
    Duquette, Pierre
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2019, 19 (07) : 695 - 706
  • [40] Adherence to disease-modifying therapies in patients with multiple sclerosis
    Koltuniuk, Aleksandra
    Rosinczuk, Joanna
    PATIENT PREFERENCE AND ADHERENCE, 2018, 12 : 1557 - 1565
12345